For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated wit ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

With demand for GLP-1 medications at an all-time high, many patients are finding themselves caught in a system that ...

The Today’s Dietitian 13th annual Spring Symposium will be returning to vibrant Orlando, Florida, in 2026. Secure your spot today by registering at www.todaysdietitian.com/ss26. We are excited to see ...

Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...

A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales ...

Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...

Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Peptide therapeutics are rapidly emerging as a promising class of interventions for obesity, driven by growing insights into their ability to modulate key ...